S-OA-M
Oral Abstracts - Session M - Leukemia
BMT Tandem "Scientific" Meeting
Texas D (Gaylord Texan)
Chairs:
Partow Kebriaei, MD
and
Robert H. Collins, MD
Disclosures:
P. Kebriaei,
Nothing To Disclose
R. H. Collins,
Nothing To Disclose
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients with Central Nervous System Involvement
Jun Aoki, MD, Tokyo Metropolitan Komagome Hospital;
Ken Ishiyama, MD, PhD, Tokyo Metropolitan Otsuka Hospital;
Shuichi Taniguchi, MD, PhD, Toranomon Hospital;
Takahiro Fukuda, MD, National Cancer Center Hospital;
Kazuteru Ohashi, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital;
Hiroyasu Ogawa, MD, PhD, Hyogo College of Medicine;
Yasuo Morisima, MD, PhD, Aichi Cancer Center Research Institute;
Tokiko Nagamura, MD, PhD, Institute of Medical Science, University of Tokyo;
Yoshiko Atsuta, MD, PhD, Nagoya University Graduate School of Medicine;
Hisashi Sakamaki, MD, PhD, Tokyo Metropolitan Komagome Hospital;
Akiyoshi Tkami, MD, PhD, Kanazawa University Hospital
A ″Non-Fratricidal″ αβ-T Cell Receptor That Targets Survivin Expressed By Hematological Malignancies
Caroline Arber, MD, Center for Cell and Gene Therapy, Baylor College of Medicine;
Xiang Feng, BS, Baylor College of Medicine;
Harshal Abhyankar, MS, Baylor College of Medicine;
Helen E. Heslop, MD, Baylor College of Medicine;
Malcolm K. Brenner, MD, PhD, Baylor College of Medicine;
Patrick Barth, PhD, Baylor College of Medicine;
Gianpietro Dotti, MD, Baylor College of Medicine;
Barbara Savoldo, MD, PhD, Baylor College of Medicine
Allotransplants for Acute Myeloid Leukemia: No Impact of Extra-Medullary Leukemia on Outcomes
Sagun D. Goyal, MD, MSc, St. Louis University Medical Center;
Geoffrey L. Uy, MD, Washington University School of Medicine;
Mei-Jie Zhang, PhD, Medical College of Wisconsin;
Hai-Lin Wang, MPH, Medical College of Wisconsin;
Steven M. Devine, MD, Ohio State Medical Center;
Marcos J. G. de Lima, MD, University Hospital Case Medical Center;
Donald W. Bunjes, MD, Ulm University Hospital;
Daniel J. Weisdorf, MD, University of Minnesota
Do Patients with High Risk or Relapsed Core Binding Factor Acute Myeloid Leukemia Benefit from Salvage Allogeneic Stem Cell Transplantation?
Gabriela Hobbs, MD, Memorial Sloan-Kettering Cancer Center;
Ashwin Kishtagari, MD, Memorial Sloan Kettering Cancer Center;
Patrick Hilden, PhD, Memorial Sloan-Kettering Cancer Center;
Juliet N. Barker, MBBS, FRACP, Memorial Sloan-Kettering Cancer Center;
Ann A. Jakubowski, MD, PhD, Memorial Sloan-Kettering Cancer Center;
Esperanza Papadopoulos, MD, Memorial Sloan-Kettering Cancer Center;
Sean Devlin, PhD, Memorial Sloan-Kettering Cancer Center;
Farid Boulad, MD, Memorial Sloan-Kettering Cancer Center;
Nancy Kernan, MD, Memorial Sloan-Kettering Cancer Center;
Rachel Kobos, MD, Memorial Sloan-Kettering Cancer Center;
Peter G Steinherz, MD, Memorial Sloan-Kettering Cancer Center;
Richard O'Reilly, MD, Memorial Sloan-Kettering Cancer Center;
Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center;
Martin Tallman, MD, Memorial Sloan-Kettering Cancer Center;
Eytan Stein, MD, Memorial Sloan Kettering Cancer Center;
Miguel-Angel Perales, MD, Memorial Sloan-Kettering Cancer Center
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS) Following Intravenous Busulfan Plus Fludarabine Based Conditioning: Outcomes and Monocyte Chemo-Attractant Protein-1
Yasser Khaled, MD, Florida Hospital Cancer Institute;
Melhem Solh, MD, Florida Hospital Cancer Institute;
Megan Fondaw, Florida Hospital Cancer Institute;
Deborah Lamontagne, Florida Hospital Cancer Institute;
Anginett Batista, MT, Florida Hospital Cancer Institute;
Sauvai Chan-Fong, MT, Florida Hospital Cancer Institute;
Joanne Sullivan, Florida Hospital Cancer Institute;
Abraham J. Matar, University of Central Florida College of Medicine
A New Class of Antigen T-Cells That Redirect Bystander T-Cells to CD19 Positive Malignancies
Mireya Paulina Velasquez, Baylor College of Medicine;
Kota Iwahori, Texas Children's Cancer Center, Baylor College of Medicine;
Sunitha Kakarla, Texas Children's Cancer Center, Baylor College of Medicine;
Caroline Arber, MD, Texas Children's Cancer Center, Baylor College of Medicine;
Tania Rodriguez-Cruz, Texas Children's Cancer Center, Baylor College of Medicine;
Claudia Gerken, Texas Children's Cancer Center, Baylor College of Medicine;
Xiao-Tong Song, Baylor College of Medicine;
Stephen Gottschalk, Baylor College of Medicine
